Vimarsana
Biggest News Aggregation in the World

Page 7 - Preference Management Solution News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Preference Management Solution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Preference Management Solution Today - Breaking & Trending Today

HiberCell commences Phase Ia/b trial of HC-7366 for solid tumours - Vimarsana News

HiberCell commences Phase Ia/b trial of HC-7366 for solid tumours

HiberCell has commenced a first-in-human Phase Ia/b clinical trial of HC-7366 to treat advanced solid tumour patients.

UK MHRA grants approval for Skymount's Covid-19 oral therapeutic trial - Vimarsana News

UK MHRA grants approval for Skymount's Covid-19 oral therapeutic trial

The UK MHRA has granted approval to commence a clinical trial of Skymount Medical’s new oral treatments for mild to moderate Covid-19.

OliPass begins dosing in Phase IIa trial of pain killer for osteoarthritis - Vimarsana News

OliPass begins dosing in Phase IIa trial of pain killer for osteoarthritis

OliPass Corporation has initiated the dosing of subjects in Phase IIa trial of pain killer OLP-1002 for osteoarthritis patients with pain.

Unlearn.AI and Merck KGaA collaborate to expedite immunology trials - Vimarsana News

Unlearn.AI and Merck KGaA collaborate to expedite immunology trials

Unlearn.AI and Merck KGaA have signed a partnership to expedite late-stage immunology trials using new designs that comprise Digital Twins.

Can Huntington's disease clinical trial design tweaks lead to success? - Vimarsana News

Can Huntington's disease clinical trial design tweaks lead to success?

After a series of disappointing clinical trial data in Huntington’s disease, study design changes take aim at moving the field forward.